India's Piramal Healthcare in talks to buy US-based Cambridge Major Laboratories for $200m
|
|
Washington, June 17 (ANI): India's Piramal Healthcare Ltd. is in talks to buy U.S.-based contract drug maker Cambridge Major Laboratories for over 200 million dollars, a source has confirmed.
"Early stage negotiations are on and it will take a while to conclude the deal," Fox News quoted the person with direct knowledge of the matter, as saying.
The Indian drug maker is the flagship company of the Ajay Piramal-owned Piramal Group, while unlisted Cambridge Major Laboratories is known for making pharmaceutical intermediates and active pharmaceutical ingredients that are used in drugs.
Both Piramal Healthcare and Cambridge Major Laboratories declined to make any comments. (ANI)
Read More: Cambridge Road | Indian Press | Srp Group Area Tso Nadiad | Srp Group I | Matri Indian Antartic Station | June Pargaon | India Security Press | June Mohide | Survey Of India | State Bank Of India | A.c.company | June Belgaum | Indian Institute Of Technology | June Belda | Indian School Of Mines | Air India | Indian Rail | Central Institute of Indian Language | Pondicherry University Latest News | National Democratic Alliance (India)
|
|
|
|
|
|
|
|
|||||
Comments: